Group One Trading’s Benitec Biopharma BNTC Stock Holding History

Group One Trading’s Portfolio BNTC Stock Details BNTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$948	Hold	89	–	–	﹤0.01%	7220
2025 Q4	$1.2K	Hold	89	–	–	﹤0.01%	7670
2025 Q3	$1.25K	Hold	89	–	–	﹤0.01%	8019
2025 Q2	$1.04K	Hold	89	–	–	﹤0.01%	7552
2025 Q1	$1.16K	Hold	89	–	–	﹤0.01%	7143
2024 Q4	$1.12K	Hold	89	–	–	﹤0.01%	6863
2024 Q3	$818	Hold	89	–	–	﹤0.01%	6320
2024 Q2	$622	Hold	89	–	–	﹤0.01%	6429
2024 Q1	$456	Hold	89	–	–	﹤0.01%	6753
2023 Q4	$288	Hold	89	–	–	﹤0.01%	7137
2023 Q3	$269	Buy	89 +1	+1%	+$3	﹤0.01%	7413
2023 Q2	$358	Hold	88	–	–	﹤0.01%	7401
2023 Q1	$315	Hold	88	–	–	﹤0.01%	6956
2022 Q4	$255	Sell	88 -12	-12%	-$41	﹤0.01%	7021
2022 Q3	$1K	Sell	100 -18	-15%	-$229	﹤0.01%	7274
2022 Q2	$2K	Hold	118	–	–	﹤0.01%	7377
2022 Q1	$5K	Hold	118	–	–	﹤0.01%	7442
2021 Q4	$5K	Hold	118	–	–	﹤0.01%	7619
2021 Q3	$7K	Buy	+118	New	+$7.75K	﹤0.01%	7627

Other funds holding BNTC

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Group One Trading's BNTC Position: Q1 2026 in Review

Group One Trading held its Benitec Biopharma (BNTC) position steady in Q1 2026 at 89 shares worth $948. The position accounts for ﹤0.01% of the portfolio, ranked #7220.

Group One Trading first reported a position in BNTC in Q3 2021 and has held it in 19 quarters since. The position peaked at $7K in Q3 2021. 88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

Group One Trading held 89 shares of Benitec Biopharma worth $948 as of Q1 2026.
Group One Trading left its Benitec Biopharma share count unchanged in Q1 2026.
Benitec Biopharma made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7220 holding.
Group One Trading first reported a position in Benitec Biopharma in Q3 2021 and has held it in 19 quarters since.
Group One Trading's Benitec Biopharma position peaked at $7K in Q3 2021.
88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.